CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
1-Year Return
42.86%
This Quarter Return
+12.24%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$1.41B
AUM Growth
-$171M
(-11%)
Cap. Flow
-$62.5M
Cap. Flow
% of AUM
-4.42%
Top 10 Holdings %
Top 10 Hldgs %
67.5%
Holding
33
New
7
Increased
5
Reduced
12
Closed
3
Top Buys
| 1 |
Iovance Biotherapeutics
IOVA
|
$116M |
| 2 |
Insmed
INSM
|
$43.8M |
| 3 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$30.9M |
| 4 |
EPZM
Epizyme, Inc
EPZM
|
$16.1M |
| 5 |
Omeros
OMER
|
$14.5M |
Top Sells
| 1 |
Myriad Genetics
MYGN
|
$110M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$46.1M |
| 3 |
Pacira BioSciences
PCRX
|
$37.1M |
| 4 |
United Therapeutics
UTHR
|
$35.5M |
| 5 |
Vericel Corp
VCEL
|
$25.6M |
Sector Composition
| 1 | Healthcare | 95.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Krystal Biotech
KRYS
$4.35B
| $7.33M | 0.52% |
+182,090
| New | +$7.33M |
|
27
Savara
SVRA
$643M
| $3.72M | 0.26% |
1,568,002
-1,525,688
| -49% | -$3.62M |
|
|
IMMU
28
DELISTED
Immunomedics Inc
IMMU
| $2.01M | 0.14% |
145,000
| – | – |
|
|
ARQL
29
DELISTED
Arqule Inc
ARQL
| $551K | 0.04% |
+50,000
| New | +$551K |
|
30
Q32 Bio
QTTB
$20.4M
| $512K | 0.04% |
+1,453
| New | +$512K |
|
31
Akebia Therapeutics
AKBA
$785M
| – | – |
-1,430,579
| Closed | -$11.7M |
|
|
32
Myriad Genetics
MYGN
$615M
| – | – |
-3,309,206
| Closed | -$110M |
|